Head-to-head · Comparison
Features, pricing, health score, community ratings — side-by-side from the live MadeOnSol database.
Updated August 4, 2026
![]() | ||
|---|---|---|
| Rating | (0) | (5) |
| Pricing | Free | Free |
| Health | Healthy | Healthy |
| Chain | solana only | multi chain |
| Open Source | ||
| Features | 4 features | 8 features |
| Upvotes |
Pros & cons
Analysis
Arrakis Arrakis provides automated liquidity management for concentrated-liquidity AMMs, aimed primarily at protocols and token issuers that need to run market making on their own token without staffing a tra... DEXScreener DEXScreener is a real-time decentralized exchange analytics platform that tracks trading activity across multiple blockchains, with particularly strong coverage of Solana. It has become one of the mos...
DEXScreener is rated higher by the MadeOnSol community with 5.0/5 stars across 5 reviews, compared to 0.0/5 for Arrakis (0 reviews). That said, ratings only tell part of the story — what matters most is which tool fits your specific workflow.
Arrakis uses a free model, while DEXScreener is free — Free to use with no account required. Paid services for projects: token profile updates/boosts cost $299-$999+.. Both tools are free, so cost isn't a deciding factor — focus on features and reliability instead.
Arrakis offers 4 features including Automated rebalancing of concentrated liquidity positions, Non-custodial vaults - depositors retain control of underlying assets, Strategies aimed at protocol treasuries and token issuers rather than retail LPs, and 1 more. DEXScreener counters with 8 features including Real-time price charts with sub-second data updates across all chains, Multi-chain coverage including Solana, Ethereum, Base, BSC, and 20+ networks, Token discovery with trending, new pairs, top gainers, and boosted listings, and 5 more. The right choice depends on which specific features matter for your use case — check the individual review pages for full breakdowns.
We monitor both tools around the clock for uptime, SSL validity, and response times. Arrakis currently has a healthy health status with 100.0% uptime over the last 30 days. DEXScreener is rated healthy with 100.0% uptime. For any tool you trust with your funds, trades, or yield, uptime and speed are non-negotiable.
Arrakis's key strengths include removes the manual overhead of managing concentrated liquidity ranges, well suited to a chain with constant new-token issuance, non-custodial design avoids handing assets to a market maker.
More comparisons
Compare Arrakis with…
Compare DEXScreener with…
Explore more
Keep comparing
DEXs, RPC providers, liquid-staking protocols, and trading-bot fees — all compared the same way.
| ▲ 0 |
| ▲ 7 |
| Twitter Followers | — | 230,742 |
| Categories | DeFi & Yield | Analytics & Charts |
| Description | Automated market making and liquidity management for token teams | Real-time DEX charts and trading data across all chains |
While Arrakis (DeFi & Yield) and DEXScreener (Analytics & Charts) serve different primary purposes, users often consider both when building their Solana toolkit. DEXScreener has the community's vote, but your mileage may vary depending on your specific needs. We recommend trying both — Arrakis is free to start and DEXScreener is free to start. Read user reviews on each tool's page for real-world feedback from the Solana community.